| 2007 | Sequential expression of NKCC2, TonEBP, aldose reductase, and urea transporter-A in developing mouse kidney | 한기환 | Article |
| 2012 | Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis. | 문영철 | Meeting Abstract |
| 2011 | Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis | 문영철 | Meeting Abstract |
| 2016 | Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial | 심기남 | Article |
| 2008 | Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial | 성주명 | Meeting Abstract |
| 2007 | Sequential VAD (vincristine, adriamycin, dexamethasone) and VTD (VELCADE (R), thalidomide, dexamethasone) induction followed by high-dose therapy with autologous stem cell transplantation and maintenance treatment with VELCADE for newly diagnosed multiple myeloma: Interim results of phase II trial | 성주명 | Meeting Abstract |
| 2012 | Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: Results of a phase II trial | 성주명 | Article |
| 2024 | Serial Comparison of Patient-Reported Outcomes of Immediate Breast Reconstruction: Direct-to-Implant Versus Deep Inferior Epigastric Perforator Flap | 우경제; 박진우 | Article |
| 2012 | Serial serum cholinesterase activities as a prognostic factor in organophosphate poisoned patients | 전영진; 최윤희 | Article |
| 2024 | Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System | 최정윤; 이정연 | Article |
| 2011 | Seroepidemiology of hepatitis A in Korea: Changes over the past 30 years | 김경효 | Article |
| 2013 | Seroepidemiology of varicella-zoster virus in Korea | 김경효 | Article |
| 2012 | Seroprevalence of Helicobacter pylori in female Vietnamese immigrants to Korea | 이선영; 박혜숙; 박보현 | Article |
| 2018 | Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016 | 정혜경 | Article |
| 2016 | Seroprevalence of Helicobacter pylori in Korea; multicenter, nationwide study in 2015 | 정혜원 | Meeting Abstract |
| 2018 | Seroprevalence of opsonophagocytic antibodies against serotype Ia, Ib, II, III, and V Group B streptococcus among Korean population | 김경효; 김한울 | Article |
| 2016 | Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants | 김경효; 김한울 | Article |
| 2016 | Serotype 6B from a pneumococcal polysaccharide vaccine induces cross-functional antibody responses in adults to serotypes 6A, 6C, and 6D | 김경효; 김한울 | Article |
| 2019 | Serotype Distribution and Antimicrobial Resistance of Invasive and Noninvasive Streptococcus pneumoniae Isolates in Korea between 2014 and 2016 | 이미애 | Article |
| 2022 | Serotype Distribution and Antimicrobial Resistance of Salmonella Isolates in Korea between 2016 and 2017 | 이미애 | Article |
